Staffline Share Discussion Threads

[tia01] 22/3/2022 20:48

Need good news tomorrow from the meeting and we’re going again 50 day crossing 200 day moving average is crucial for the share price rise.

[tia01] 22/3/2022 17:58

Marry Poppins
The one who said 35p. What a 🃏. The biggest 🤡. You should have listened I told you enough times at 40p. Now I’m sat on 60% rise in nearly 3 weeks and over 100% on my entire Staffline holdings from 2020. Blue skys ahead. Hopefully someone asked about dividends tomorrow. We’ll capitalised and net profits again so no issues. Two contract wins and turned a dead horse in to a galloping one.
People don’t think think the management deserve bonuses. Well without these guys the company would have gone under so bonuses justified personally. Just hope they invest it back in Staffline after closed period.
Perfect figures and profit per customer rising.
You never listen Marry last time. Under what a Golden Cross is and let me know in a few months where the price is. Top of the uptrend peaks is around £1.07p so I’m happy to sit this out. Maybe I should have been a prize 🐓 like u and took 1% in a imaginary bank.
Prize 🤡

[km18] 22/3/2022 17:08

Staffline Group Plc published FY21 results this morning. Revenue increased to £942.7m (2020: £927. 6m). Strong organic growth in like for like revenue and gross profit more than doubled year-on-year underlying operating profits. The company posted its first profit after tax since 2017, up to £1.6m from a loss of -£48.5m last year. The Group's balance sheet continues to strengthen following the equity raise of £46.4m in June 2021 and refinancing of the Group's working capital facilities. Net cash was £6.9m at 31 December 2021. Valuation is decent, PS ratio in particular is top decile for the Professional & Commercial Services market. The business looks to be turning around and moving back to profit, the top line is heading back up. But there remains no dividend and there is no compelling reason to buy here. Not a bad recruitment company and certainly worth monitoring, but no rush to buy....

...from WealthOracleAM

[maryhopkins] 22/3/2022 16:37

How's that imaginary long from 40p on 4th March going Smelly? You really do have some serious mental health issues!

[qsmeily456] 22/3/2022 16:22

💩grip ....44p to 65p is 40% u lost u 🐓🤣

[tia01] 22/3/2022 12:05

Gripper
Prize 🐓
Couldn’t buy 100,000 at 40p

Prize 🍩🃏

[qsmeily456] 22/3/2022 11:56

Then email the CEO and CFO and ask the questions tomorrow 🤣🤣🤣

Indiestu

22 Mar '22 - 08:51 - 1509 of 1517

0  2 0

Group costs, which include Directors' remuneration costs, have increased due to the inclusion of bonus awards for the Executive Directors. no money for a dividend and no statement regarding a future dividend policy.

The results are poorly presented and misleading to the point of being dishonest.

[qsmeily456] 22/3/2022 11:54

All new posters talking 🐃💩 like I'm out 🤣 great now naff off u 🐓

[my retirement fund] 22/3/2022 11:46

What's the working capital position? - not really important, so many options not like they need inventory is it, can do invoice discounting and run on an overdraft if they wanted to! As it has been in the past and back then the share price was multiples of what it is today. This is looking like a good recovery.

[babbler] 22/3/2022 11:25

Stronger than expected trading cash flow has reduced ongoing finance costs materially to GBP2.4m (2020: GBP4.1m)

[kemche] 22/3/2022 11:16

"Throwing of loads of cash, extremely solvent, excellent cash war chest,"

Are you reading a different cashflow statement?

What's the working capital position?

[my retirement fund] 22/3/2022 10:40

no end to russia but plenty of defence jobs

[gripfit] 22/3/2022 10:22

Perhaps they may dig into THEIR pockets and BUY some shares …

[indiestu] 22/3/2022 10:14

If you use 2019 revenues for a comparator, as opposed to 2020's Covid impacted results it is clear that the business is in still in decline. Following a huge fund raise you would expect the companies financial position to be stronger at year end. The Directors care little for shareholders. The Directors have all received bonuses whilst diluting shareholders. A statement regarding a future dividend policy would have been courteous. As they are unable to provide this statement they have no confidence to forecast whether any cash will be available to shareholders in 2022. To claim strong organic growth YOY using 2020 as a comparator is questionable.

[dr biotech] 22/3/2022 10:04

Lol. When did you buy in? fantasy trader. Results and more importantly outlook seem decent enough.


Russia does concern mw though, hard to see end game.

[currencytrader1] 22/3/2022 09:56

Im out, next dump of bad news due re Russia, economy and covid. Ill be back in again im sure...

[my retirement fund] 22/3/2022 09:23

misleading to the point of being dishonest - looks pretty clear to me, what bit did you not understand?

[john09] 22/3/2022 09:18

Ok well you can start with why the results are dishonest

[indiestu] 22/3/2022 09:10

It's never too early to start a debate. ;-)

[john09] 22/3/2022 09:03

Indiestu

Its a bit early to smoke weed

[maryhopkins] 22/3/2022 08:56

Does that include tia aka smelly with its imaginary long from 40p on 4th March?

[indiestu] 22/3/2022 08:53

Group costs, which include Directors' remuneration costs, have increased due to the inclusion of bonus awards for the Executive Directors. No bonuses were paid for 2020.That's nice. Shareholders diluted. Statutory loss before tax, statutory loss per share, net debt position post IFRS 16, no money for a dividend and no statement regarding a future dividend policy.The results are poorly presented and misleading to the point of being dishonest.

[indiestu] 22/3/2022 08:51

Group costs, which include Directors' remuneration costs, have increased due to the inclusion of bonus awards for the Executive Directors. No bonuses were paid for 2020.That's nice. Shareholders diluted. Statutory loss before tax, statutory loss per share, net debt position post IFRS 16, no money for a dividend and no statement regarding a future dividend policy.The results are poorly presented and misleading to the point of being dishonest.

[qsmeily456] 22/3/2022 08:40

🤣🤣🤣🤣